TRANSFORMED LYMPHOMA
Clinical trials for TRANSFORMED LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug may stop aggressive lymphoma relapse after transplant
Disease control Recruiting nowThis study tests whether the drug acalabrutinib can help prevent relapse in people with very high-risk large B-cell lymphoma after they have received cell therapy (stem cell transplant or CAR T-cells). About 24 adults aged 18-70 will take acalabrutinib as a maintenance treatment.…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:34 UTC
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase study tests whether a personalized cell therapy (CAR-T cells) is safe for people with certain types of Non-Hodgkin lymphoma that have come back or not responded to standard treatments. Up to 36 participants will receive their own immune cells that have been genet…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1 • Sponsor: C. Babis Andreadis • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New antibody therapy aims to prevent lymphoma return after transplant
Disease control Recruiting nowThis early-phase study tests whether adding a drug called mosunetuzumab after a stem cell transplant is safe and doable for people with aggressive B cell lymphoma that has come back or not responded to prior treatments. Mosunetuzumab is an engineered antibody that helps the body'…
Matched conditions: TRANSFORMED LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC